| Net Cash Provided by (Used in) Operating Activities |
$2,409,589 |
USD |
-6.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$217,238 |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,993,128 |
USD |
-98% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
15,089,600 |
shares |
12% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,783,684 |
USD |
-55% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,176,700 |
USD |
-30% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$4,533,600 |
USD |
-26% |
Q4 2024 |
FY 2024 |
| Depreciation |
$543,122 |
USD |
19% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,408,468 |
USD |
337% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$3,661,000 |
USD |
-30% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$59,946 |
USD |
97% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,356,900 |
USD |
-14% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |